A four-week, randomized, double-blind trial of the efficacy and safety of SKI306X: A herbal anti-arthritic agent versus diclofenac in osteoarthritis of the knee

American Journal of Chinese Medicine

Volumn 32, Issue 2, 2004, Pages 291-301

  Jung, Young Bok ^a   Seong, Sang Cheol ^b   Lee, Myung Chul ^b   Shin, Yong Un ^b   Kim, Dong Han ^b   Kim, Jung Man ^c   Jung, Yang Kuk ^c   Ahn, Jin Hwan ^d   Seo, Jai Gon ^d   Park, Youn Soo ^d   Lee, Chong Suh ^d   Roh, Kwon Jae ^e   Han, Chang Kyun ^f   Cho, Yong Baik ^f   Chang, Don Yong ^f   Kwak, Wie Jong ^f   Jung, Kui Oak ^g   Park, Byung Joo ^g,h  

^a Chung Ang University   (South Korea)

^b Seoul National University   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Sungkyunkwan University   (South Korea)

^e Ewha Womans University   (South Korea)

^f SK Chemicals   (South Korea)

^g Seoul National University Hospital   (South Korea)

^h Seoul National University College of Medicine   (South Korea)

Author keywords

Anti arthritis agent; Clematis radix; Diclofenac; Osteoarthritis; Prunella spike; SKI306X; Trichosanthes root

Indexed keywords

ANTACID AGENT; ANTICOAGULANT AGENT; ANTIRHEUMATIC AGENT; CORTICOSTEROID; DICLOFENAC; HERBACEOUS AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; SKI 306X; STEROID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CHI SQUARE TEST; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; EXERCISE; FEMALE; GASTROINTESTINAL SYMPTOM; HEARTBURN; HUMAN; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MASSAGE; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SCORING SYSTEM; SKIN DISEASE; SUSTAINED RELEASE FORMULATION; UROGENITAL TRACT DISEASE; VISUAL ANALOG SCALE;

ADMINISTRATION, ORAL; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DELAYED-ACTION PREPARATIONS; DICLOFENAC; DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; KNEE JOINT; MALE; MIDDLE AGED; OSTEOARTHRITIS; PATIENT SATISFACTION; TREATMENT OUTCOME;

EID: 20844441276     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X04001941     Document Type: Article

References (17)

1. Ahn, J.S., H.T., Kim, Y.B. Cho, H.S. Kim, K.S. Park and P.U. Park. Acute toxicity of SKI306X: an antiinflammatory herbal extract in rats. J. Appl. Pharmacol. 1: 32-35, 1996.
2. Altman, R., E. Asch, D. Bloch, G. Bole, D. Borenstein, K. Brandt, W. Christy, T.D. Cooke, R. Greenwald, M. Hochberg, D. Howell, D. Kaplann, W. Koopman, S. Longley, H. Mankin, S.J. McShane, T. Medsger, R. Meenan, W. Mikkelsen, R. Moskowitz, W. Murphy, B. Rothschild, M. Segal, L. Sokoloff and F. Wolfe. Development of criteria for the classification and reporting of osteoarthritis. Arthritis Rheum. 29(8): 1039-1049, 1986.
3. Amundsen, T., L. Bleken, B. Borkje, W. Eidsaunet, P. Eidsbo, S. Larsen, R. Finstad, T. Quamme, L. Sandvik, P.H. Staff, J. Sorie and J. Utne-Sorensen. Variation in response to naproxen and diclofenac in patients with osteoarthritis. Curr. Ther. Res. 33: 793-801, 1993.
4. Bellamy, N., W.W. Buchanan, A. Chalmers, P.M. Ford, W.F. Kean, G.R. Kraag, E. Gerecz-Simon and J. Campbell. A multicentre study of tenoxicam and diclofenac in patients with osteoarthritis of knee. J. Rheumatol. 20: 999-1004, 1993.
5. Brandt, K.D., St. Kovalov and K. John. Osteoarthritis. In: J.D. Wilson, E. Braunwald and K.J. Isselbacher, et al. (eds.) Harrison's Principles of Internal Medicine, 13th ed. McGraw-Hill, New York, 1991, pp. 1475-1479.
6. Choi, J.H., J.H. Choi, D.Y. Kim, J.H. Yoon, H.Y. Yoon, J.B. Yi, H.I. Rhee, K.H. Rhy, C.K. Han, W.J. Kwak and Y.B. Cho. Effects of SKI306X, a new herbal agent, on proteoglycan degradation in cartilage explant culture and collagenase-induced rabbit osteoarthritis model. Osteoarthritis Cartilage 10(6): 471-478, June 2002.
7. Chow, S.C. and J.P. Liu. Designs and Analysis of Bioavailability and Bioequivalence Studies. Dekker, New York, 1992.
8. Fries, J.F. NSAID gastropathy: the second most deadly rheumatic disease. Epidemiology and risk appraisal. J. Rheumatol. 18(Suppl. 28): 6-10, 1991.
9. Jung, Y.B., K.J. Roh, J.A. Jung, K.W. Jung, H.S. Yoo, Y.B. Cho, W.J. Kwak, D.K. Kim, K.H. Kim and C.K. Han. Effect of SKI306X: a new herbal anti-arthritic agent, in patients with osteoarthritis of the knee: a double-blind placebo controlled study. Am. J. Chin. Med. 29(3-4): 485-491, 2001.
10. Kim, H.T., J.S. Ahn, I.H. Jeong, T.S. Kim, K.H. Ryu, G.J. Im, Y.B. Cho, D.K. Kim, H.S. Kim, K.S. Park, K.H. Kim, P.U. Park, H.S. Ann and I.H. Huh. Subacute toxicity of SKI306X: an antiinflammatory herbal extract, in rats. J. Appl. Pharmacol. 1: 19-31, 1996.
11. Kirchheiner, B., L. Trang and F.A. Wollheim. Diclofenac sodium (Voltaren) in rheumatoic arthritis: a double-blind comparison with indomethacin and placebo. Int. J. Clin. Pharmacol. 13: 292-297, 1976.
12. Lane, N.E. Pain management in osteoarthritis: the role of COX-2 inhibitors. J. Rheumatol. 24(Suppl. 49): 20-24, 1997.
13. Lund, B., M. Distel and E. Bluhmki. A double-blind, randomized, placebo-controlled study of efficacy and tolerance of meloxicam treatment in patients with osteoarthritis of the knee. Scand. J. Rheumatol. 27(1): 32-37, 1998.
14. Murray, M. and D. Brater. Adverse effects of non-steroidal anti-inflammatory drug on renal function. Ann. Intern. Med. 112: 559-560, 1990.
15. Park, K.S., H.S. Kim, J.S. Ahn, T.S. Kim, P.U. Park, W.J. Kwak, C.K. Han, Y.B. Cho and K.H. Kim. Preparation of antiinflammatory herbal drug, SKI306X. Yakhak Hoeji 39: 385-394, 1995.
16. Todd, P.A. and E.M. Sorkin. Diclofenac sodium. A re-appraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs 35: 244-285, 1998.
17. Vane, J.R. and R.M. Botting. New insights into the mode of action of anti-inflammatory drugs. Inflamm. Res. 44: 1-10, 1995.